Indeed, I recently wrote about the fact that clinicians should be open to tweaking dose quantity and scheduling based on individual patients responses, rather than just monolithically concluding that a patient having nasty side effects in the dose escalation phase should just give up on the medications entirely
Pedro Rozas Moreno
Supplementary material The Supplementary Material for this article can be found online at: References 1
Antibodies against MARCO (Abcam, clone EPR22944-66, catalog ab259264, 1:200), F4/80 (Invitrogen, Thermo Fisher Scientific, clone CI:A3-1, catalog MA1-91124, 1:250), and CLEC4F (R&D Systems, Bio-Techne, catalog AF2784, 1:200) were incubated overnight at 4C
If your hair loss is accompanied by fatigue, cold intolerance, dry skin, or unexpected changes in weight loss rate, check thyroid function immediately
Kraemer, J.S